World's Best Scientists 2026 revealed!
Florian Lordick

Florian Lordick

D-Index & Metrics

Medicine

D-Index
101
Citations
54878
World Ranking
7812
National Ranking
443

Florian Lordick publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Florian Lordick sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 709 publications — 82nd percentile

82% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Florian Lordick D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Florian Lordick sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 101 D-Index — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Florian Lordick is affiliated with Leipzig University in Germany and has contributed extensively to the field of medicine, with a focus on oncology and gastrointestinal cancers. Their research encompasses multiple subfields including pulmonary and respiratory medicine, surgery, gastroenterology, and radiology, nuclear medicine, and imaging.

The scientist's work centers on key topics such as gastric cancer management and outcomes, esophageal cancer research and treatment, colorectal cancer treatments and studies, gastrointestinal tumor research and treatment, lung cancer treatments and mutations, cancer immunotherapy and biomarkers, and metastasis and carcinoma case studies.

Several notable recent papers authored or co-authored by Florian Lordick include:

  • Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up, 2022, Annals of Oncology
  • Gastric cancer, 2020, The Lancet

Frequent co-authors collaborating with Florian Lordick include:

  • Ines Gockel, with 39 joint publications
  • Eric Van Cutsem, with 28 joint publications
  • Kohei Shitara, with 26 joint publications
  • Sylvie Lorenzen, with 25 joint publications
  • Jaffer A. Ajani, with 22 joint publications

Publication venues where Florian Lordick has published frequently include:

  • Annals of Oncology, with 38 publications
  • Journal of Clinical Oncology, with 27 publications
  • ESMO Open, with 13 publications
  • Journal of Cancer Research and Clinical Oncology, with 13 publications
  • Die Onkologie, with 13 publications

The main field of study for Florian Lordick is medicine, with a record of 709 associated publications. Subfields with the highest publication counts include pulmonary and respiratory medicine (224), oncology (172), surgery (119), gastroenterology (39), and radiology, nuclear medicine, and imaging (36).

Best Publications

  • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

    Yung Jue Bang;Eric Van Cutsem;Andrea Feyereislova;Hyun C. Chung

  • Randomized Phase III Study of Panitumumab With Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) Compared With FOLFIRI Alone As Second-Line Treatment in Patients With Metastatic Colorectal Cancer

    Marc Peeters;Timothy Jay Price;Andrés Cervantes;Alberto F. Sobrero

  • Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.

    Gunnar Folprecht;Thomas Gruenberger;Wolf O Bechstein;Hans-Rudolf Raab

  • Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

    Florian Lordick;Yoon Koo Kang;Hyun Cheol Chung;Pamela Salman

  • PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial.

    Florian Lordick;Katja Ott;Bernd-Joachim Krause;Wolfgang A Weber

  • Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    F. Lordick;C. Mariette;K. Haustermans;Radka Obermannová

  • Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954.

    Christoph Schuhmacher;Stephan Gretschel;Florian Lordick;Peter Reichardt

  • Randomized Phase III KEYNOTE-181 Study of Pembrolizumab Versus Chemotherapy in Advanced Esophageal Cancer

    Takashi Kojima;Manish A Shah;Kei Muro;Eric Francois

  • Neoadjuvant Chemoradiotherapy Followed by Surgery Versus Surgery Alone for Locally Advanced Squamous Cell Carcinoma of the Esophagus (NEOCRTEC5010): A Phase III Multicenter, Randomized, Open-Label Clinical Trial.

    Hong Yang;Hui Liu;Yuping Chen;Chengchu Zhu

  • Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment

    Hinrich A. Wieder;Björn L.D.M. Brücher;Frank Zimmermann;Karen Becker

  • Metabolic imaging predicts response, survival, and recurrence in adenocarcinomas of the esophagogastric junction.

    Katja Ott;Wolfgang A. Weber;Florian Lordick;Karen Becker

  • Efficacy and Safety of Pembrolizumab for Heavily Pretreated Patients With Advanced, Metastatic Adenocarcinoma or Squamous Cell Carcinoma of the Esophagus: The Phase 2 KEYNOTE-180 Study.

    Manish A. Shah;Takashi Kojima;Daniel Hochhauser;Peter Enzinger

  • A phase III, double-blind, randomized trial of palonosetron compared with ondansetron in preventing chemotherapy-induced nausea and vomiting following highly emetogenic chemotherapy

    M S Aapro;S M Grunberg;G M Manikhas;G Olivares

  • Prediction of response to preoperative chemotherapy in gastric carcinoma by metabolic imaging: results of a prospective trial.

    Katja Ott;Ulrich Fink;Karen Becker;Alexander Stahl

  • ESOPEC: prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)

    Jens Hoeppner;Florian Lordick;Thomas Brunner;Torben Glatz

  • Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical Trial.

    Manish A. Shah;Yung Jue Bang;Florian Lordick;Maria Alsina

  • Efficacy results from the ToGA trial: A phase III study of trastuzumab added to standard chemotherapy (CT) in first-line human epidermal growth factor receptor 2 (HER2)-positive advanced gastric cancer (GC)

    E. Van Cutsem;Y. Kang;H. Chung;L. Shen

  • Multicenter Phase II Trial of Chemoradiation With Oxaliplatin for Rectal Cancer

    Claus Rödel;Torsten Liersch;Robert Michael Hermann;Dirk Arnold

  • Cetuximab plus cisplatin–5-fluorouracil versus cisplatin–5-fluorouracil alone in first-line metastatic squamous cell carcinoma of the esophagus: a randomized phase II study of the Arbeitsgemeinschaft Internistische Onkologie

    S. Lorenzen;T. Schuster;R. Porschen;S.-E. Al-Batran

  • [German S3-Guideline "Diagnosis and Treatment of Esophagogastric Cancer"]

    M. Moehler;Se-E. Al-Batran;T. Andus;M. Anthuber

Frequent Co-Authors

Christian Peschel
Christian Peschel Technical University of Munich
Markus Schwaiger
Markus Schwaiger Technical University of Munich
Ken Herrmann
Ken Herrmann German Cancer Research Center
Michel Ducreux
Michel Ducreux Institut Gustave Roussy
Heinz Höfler
Heinz Höfler Technical University of Munich
J. R. Siewert
J. R. Siewert University of Freiburg
Andrés Cervantes
Andrés Cervantes University of Valencia
Anja Mehnert
Anja Mehnert Leipzig University
Volker Heinemann
Volker Heinemann Ludwig-Maximilians-Universität München

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical career in the USA offers a variety of online educational pathways beyond the traditional medical degree. Specialized programs can prepare students for advanced practice, healthcare management, or allied health roles, often with added flexibility and affordability.

For those aiming for high-level nursing careers, the best online dnp programs allow registered nurses to earn the Doctor of Nursing Practice, equipping them for leadership roles in patient care. Pharmacists can advance their expertise with pharmacy school online options, which provide rigorous training in pharmaceutical sciences and clinical practice.

Beyond clinical roles, the healthcare industry also relies on professionals skilled in data and administration. Earning a health information management degree online prepares graduates to manage critical patient data and health informatics systems. Meanwhile, certification programs, such as medical billing and coding certification online, open doors to vital support positions in healthcare without committing to a multi-year degree.

These diverse online degrees and certifications create multiple entry points and career advancement opportunities within the healthcare sector.

Best Scientists Citing Florian Lordick

Trending Scientists

Recently Published Articles